← All research updates

Scientists redesign a virus shell to better reach brain tumor cells in the lab

Original title: Shifting AAV9 tropism by binding moiety insertion enhances transduction of tumor cell lines and human glioblastoma explants.

How far along is this research?

This was done on cells in a lab, not in people. It is a very early step.

This was only done on cells and tumor tissue in the lab, not in people.

The short version

Researchers changed a harmless delivery virus so it sticks to brain tumor cells better, but this work was only done in the lab.

What was studied. Researchers built changed versions of a delivery virus called AAV, which is already used in some gene therapies. They added a small binding piece that grabs onto EGFR, a marker often found in high amounts on glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells, and also tested a piece of scorpion venom called chlorotoxin.

What they found. The changed virus shells got into cells better when EGFR was present. The AAV9 versions with the EGFR binding piece worked better than the unchanged AAV9. Several of these versions also got into pieces of tumor tissue taken from patients during surgery, which the team checked under a microscope.

What this means, and what it doesn't

What it could mean: This is early work on a delivery tool, not a treatment. If this kind of targeting keeps working, it could one day help send a therapy to tumor cells instead of healthy ones. Testing it on real tumor tissue from surgery is a useful early check.

What it doesn't mean: This does not mean there is a new treatment. Nothing here was given to a person. The work was done on cells in a dish and on tumor tissue in the lab, which is the earliest stage of research. It is a long way from anything a doctor could offer. It is not a promise of a cure.

Source: PubMed, August 11, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary